R. STEPHANIE KONG
** ******** **., ****** ******, NJ 07076 908-***-**** accv8y@r.postjobfree.com
SUMMARY
Highly motivated pharmaceutical scientist with extensive experience in cross-functional R&D
discovery. Proven record of delivering drug candidates from discovery to development and regulatory
filing. Proficient interpersonal, communication, and presentation skills. A bility to balance multiple tasks
to meet priorities and timelines
HIGHLIGHTS
• Self-starter with knowledge of Regulatory history, ICH/GCP guidelines on Clinical Study Report, GCP,
clinical trial design and understanding of the logistics and work of the pharmaceutical industry through on
line training:
- FDA Law and Regulation
- Global Regulatory Strategy for Pharmaceuticals
- Introduction to Regulatory Affairs in the US and Canada
- Introductory Medical Writing
- Pharmaceuticals: Definition and Lifecycle
- Regulation of US and EU Biologics
- Role of the Regulatory Professional
- Understanding and Managing the US Clinical Trial Process
- Ethics
• Effective contributor to a number of preclinical study reports to support IND and NDA filing
• Preparation of key scientific data for journal articles, patents, poster sessions and oral presentation
• Co-authored multiple manuscripts and poster abstracts for internal and external publications
• Established standard operating procedures for technology platforms to enable HCV drug
discovery
• Served as a Single Point of contact for Merck biological reagents outsourcing projects and
chemical inventory system
EDUCATION
• Regulatory Affairs Certificate: Pharmaceuticals RAPS Online University
• Master of Science in Biology Seton Hall University, South Orange, NJ
• Bachelor of Science in Biophysics FuDan University, Shanghai, P.R.China
PROFESSIONAL EXPERIENCES
Merck Research Laboratories, Kenilworth, NJ
2011.10 – 2013.11: Scientist I /Infectious Disease group
Implemented a technology platform to perform in vitro translational PK/PD studies of HCV antiviral
drugs to support First-in-Human studies for key late stage HCV program; coordinated monthly cross-
functional reviews by key opinion leaders from clinical and DMPK department to perform due
diligence and acquire new technologies
R. STEPHANIE KONG
13 Fenimore Dr., Scotch Plains, NJ 07076 908-***-**** accv8y@r.postjobfree.com
Schering-Plough Research Institute, Kenilworth, NJ
1999.11 – 2011.10: Scientist I/Virology Department
Key contributor of the HCV drug discovery team that successfully delivered SCH503034 (Victrelis) which was
approved by FDA; supported clinical trials of MK-8742 phase 1b, MK-5172 phase 2 and Vaniprevir phase 2
and 3 studies; prepared preclinical pharmacology report for the IND filing of MK-8742 and MK-5172;
collaborated extensively with other teams such as high throughput screening, chemistry and DMPK to move
program forward
Merck Research Laboratories, Rahway, NJ
1998.8 – 1999.10: Contract employee/Vaccine Group
Participated in research and development of HIV-1 Vaccine; validated target vaccine in small animal
study under GLP; working knowledge experience in regulatory guidelines for compliance on
reportable data for vaccine studies
Seton Hall University, South Orange, NJ
1996.7-1998.7: Teaching Assistant/Biology Department
Examined the actions of Morphine on the brain-immune axis; tutoring undergraduate General Biology and Cell
Biology laboratory, including instruction experimental techniques and instrument utilization
Baylor College of Medicine, Houston, TX
1994.11-1996.6: Research Assistant/Neurology Department
Conducted Alzheimer’s Disease research; prepared regular progress reports for senior management ;
complied with good housekeeping and safety practices
AWARDS
• Young Investigator Travel Awards
Drugs of abuse, Immunomodulation & AIDS (Sixth Annual Symposium)
PROFESSIONAL AFFILIATIONS
• Regulatory Affairs Professionals Society
• Professionals in the Pharmaceutical and Biotech Industry
• Medical Science Liaison and Medical Affairs Networkers
PUBLICATIONS & PRESENTATIONS AVAILABLE UPON REQUEST